Tumentia Research

About:

Tumentia is a pharmaceutical company focused on the development of new therapies for cancer patients.

Website: http://www.tumentia.com

Description:

Tumentia is a pharmaceutical company focused on the development of new therapies for cancer patients. The company was founded by graduates of the Concordia University in Montreal, Canada & the University of Wyoming in 2014. We develop novel therapies for cancer patients. Our research has resulted in five pre-clinical stage drugs that treat different types of cancers. Tumentia has been acquired by Excellence Health Inc. in October, 2017 & will now operate as a subsidiary.

Total Funding Amount:

$60M

Headquarters Location:

Casper, Wyoming, United States

Founded Date:

2014-01-01

Contact Email:

us(AT)tumentia.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2015-01-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai